Cargando…
TET2 Inhibits Differentiation of Embryonic Stem Cells but Does Not Overcome Methylation-Induced Gene Silencing
TET2 is a methylcytosine dioxygenase that is frequently mutated in myeloid malignancies, notably myelodysplasia and acute myeloid leukemia. TET2 catalyses the conversion of 5′-methylcytosine to 5′-hydroxymethylcytosine within DNA and has been implicated in the process of genomic demethylation. Howev...
Autores principales: | Norman, Louis, Tarrant, Paul, Chevassut, Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158571/ https://www.ncbi.nlm.nih.gov/pubmed/25276435 http://dx.doi.org/10.1155/2014/986571 |
Ejemplares similares
-
TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells
por: Verma, Nipun, et al.
Publicado: (2017) -
TET1 Deficiency Impairs Morphogen-free Differentiation of Human Embryonic Stem Cells to Neuroectoderm
por: Li, Hanqin, et al.
Publicado: (2020) -
Tet2-mediated epigenetic drive for astrocyte differentiation from embryonic neural stem cells
por: He, Fei, et al.
Publicado: (2020) -
Individual retrotransposon integrants are differentially controlled by KZFP/KAP1-dependent histone methylation, DNA methylation and TET-mediated hydroxymethylation in naïve embryonic stem cells
por: Coluccio, Andrea, et al.
Publicado: (2018) -
Early Expression of Tet1 and Tet2 in Mouse Zygotes Altered DNA Methylation Status and Affected Embryonic Development
por: Qi, Qi, et al.
Publicado: (2022)